BNGO
NASD Bionano Genomics, Inc.$1.45 ↓ -0.01 (-0.73%) Trading Down from the previous close of $1.46, $0.04 below the day’s high of $1.49
- YTD change
- -5.27%
- vs 20-day SMA
- -7.58%
- vs 200-day SMA
- +14.36%
Price ranges
Price & Performance
+0.28 (+23.73%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $9,414.00
- BNGO is down 5% since the beginning of the year
- BNGO is down 27% over the past 12 months
- BNGO is up 23% over the past 1 month
- 10% of all BNGO investors are betting against BNGO
BNGO reads not so good: price sits above one of the two key moving averages, the 12-month move is -26.3%.
- Previous minute
- +$0.00
- Last hour
- -$0.01
- Last 5 days
- -7.10%
- vs 8-day SMA
- -6.31%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Bionano Genomics, Inc. is a life sciences instrumentation company, which focuses on the genome analysis space. The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics. Its products include Saphyr, Bionano Chips, Bionano Prep Kits, and Bionano Data Solutions. The company was founded by Han Cao in January 2003 and is headquartered in San Diego, CA.
Competitor comparison
No peer group available for this symbol.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.